About Exemplar Genetics
Exemplar Genetics is a Healthcare company based in Sioux Center (United States) founded in 2008, and was acquired by Precigen in January 2015. Genetic miniature pig models are developed for disease research. The company has 33 employees. The company was acqui-hired. Exemplar Genetics offers products and services including Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Animal Models. Its legal entity is EXEMPLAR GENETICS LLC. Its competitors include Biocytogen, Interius Biotherapeutics and Applied StemCell; 3 of its 3 listed competitors have raised funding.
Company details
Exemplar Genetics was founded in 2008 and is based in Sioux Center, United States. Animal models using miniature pigs are developed by the company for conditions including heart disease, cystic fibrosis, cardiac arrhythmia, cancer, neuromuscular disorders, neurodegeneration, and nervous system issues, with a focus on Lonestar swine. Services offered encompass model development, regulatory support, and cloning within the biotechnology sector.
- Headquarters Sioux Center, United States
- Employees 33
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website exemplargenetics.com
- Social LinkedIn X
- Acquired by Precigen (Jan 2015)
- Legal Name Exemplar Genetics Llc
Products & Services of Exemplar Genetics
Exemplar Genetics offers a comprehensive portfolio of products and services, including Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services.
Models for testing human diseases in preclinical settings.
Gene-edited minipigs designed to meet specific client needs.
Capabilities for evaluating minipig models in research contexts.
Secure facilities for housing minipig projects securely.
In-house services to accelerate clinical path development.
Funding Insights of Exemplar Genetics
- Total Rounds 14
- Last Round Grant — $238,920
- First Round $723,154
(Sep 2008)
- Investors Count 2
Latest 10 of 14 funding rounds of Exemplar Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $238,920 | Grant | – | – | |
| Jan 2013 | $224,885 | Grant | – | – | |
| Sep 2012 | $167,065 | Grant | – | – | |
| Jun 2012 | $1.21M | Grant | – | – | |
| Jan 2012 | $300,000 | Grant | – | – | – |
| Aug 2011 | $1.37M | Grant | – | – | |
| Aug 2011 | $156,826 | Grant | – | – | |
| Aug 2011 | $1.3M | Grant | – | – | |
| Jul 2011 | $1.13M | Grant | – | – | |
| Jul 2011 | $1.25M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Exemplar Genetics
Exemplar Genetics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Precigen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases | 1998 | precigen.com | Germantown, United States |
Investor details for Exemplar Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Exemplar Genetics
4 dated milestones of Exemplar Genetics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Exemplar Genetics is founded.
- Funding First funding round of $723K.
- Funding Latest funding round, Grant, of $239K.
- Exit Acquired by Precigen.
Competitors of Exemplar Genetics
Exemplar Genetics has 3 listed competitors in our database, 3 of them funded. They include Biocytogen, Interius Biotherapeutics and Applied StemCell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics |
Detailed competitors of Exemplar Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Exemplar Genetics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exemplar Genetics
Complete news archive for Exemplar Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exemplar Genetics
Exemplar Genetics was founded in 2008.
Exemplar Genetics is headquartered in Sioux Center, United States. It is registered at Sioux Center, Iowa, United States.
Exemplar Genetics has 33 employees.
Exemplar Genetics was founded in 2008 and is based in Sioux Center, United States. Animal models using miniature pigs are developed by the company for conditions including heart disease, cystic fibrosis, cardiac arrhythmia, cancer, neuromuscular disorders, neurodegeneration, and nervous system issues, with a focus on Lonestar swine. Services offered encompass model development, regulatory support, and cloning within the biotechnology sector.
Exemplar Genetics's top competitors include Biocytogen, Applied StemCell and Interius Biotherapeutics.
Exemplar Genetics offers Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services.
Exemplar Genetics operates through Exemplar Genetics Llc.
Yes. Exemplar Genetics was acquired by Precigen in January 2015.